• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝癌致癌性β受体阻滞剂DL-ZAMI 1305的化学结构与遗传毒性活性

Chemical structure and genotoxic activity of the hepatocarcinogenic beta-blocker DL-ZAMI 1305.

作者信息

Presta M, Legati F, Chiesa R, Dell'Era P, Ragnotti G

机构信息

Department of Biomedical Sciences and Biotechnologies, School of Medicine, University of Brescia, Italy.

出版信息

Carcinogenesis. 1990 Feb;11(2):261-5. doi: 10.1093/carcin/11.2.261.

DOI:10.1093/carcin/11.2.261
PMID:1967984
Abstract

A single administration of the sex-dependent hepatocarcinogenic beta-blocker DL-1-(2-nitro-3-methyl-phenoxy)3-tert-butylamino-propan-2-ol (DL-ZAMI 1305) induces liver DNA damage, as evaluated by alkaline sucrose gradient analysis, in female but not in male Fisher 344 rats. The shift of the methyl-group from the 3-position of the aromatic ring of DL-ZAMI 1305 to the 4- and 5-position causes the progressive decrease of the genotoxic activity of the molecule. No effect on the DNA-damaging capacity of DL-ZAMI 1305 is instead observed when the NO2 group of the aromatic ring is reduced to an NH2 group. Bis-demethylation of the side chain of DL-ZAMI 1305, or its modification to an alpha-hydroxicarboxylic acid or glycol, increases the DNA-damaging capacity of the molecule, which becomes genotoxic also for the liver of the male rat. Thus, modifications of the chemical structure of the aromatic ring or of the side chain of DL-ZAMI 1305 affect the genotoxic activity of the molecule both in male and female rat liver. The modifications of the side chain of DL-ZAMI 1305 investigated in the present work are likely to occur in vivo as a consequence of the hepatic metabolism of the molecule. Sex-dependent differences in the activity of the liver drug-metabolizing system might explain the different genotoxic and oncogenic activity of DL-ZAMI 1305 in the two sexes.

摘要

单次给予具有性别依赖性的致癌β受体阻滞剂DL-1-(2-硝基-3-甲基苯氧基)-3-叔丁氨基-2-丙醇(DL-ZAMI 1305)后,通过碱性蔗糖梯度分析评估发现,雌性Fisher 344大鼠肝脏出现DNA损伤,而雄性大鼠未出现。DL-ZAMI 1305芳香环3位上的甲基转移至4位和5位会导致该分子遗传毒性活性逐渐降低。相反,当芳香环的NO2基团还原为NH2基团时,未观察到对DL-ZAMI 1305的DNA损伤能力有影响。DL-ZAMI 1305侧链的双去甲基化,或将其修饰为α-羟基羧酸或二醇,会增加该分子的DNA损伤能力,其对雄性大鼠肝脏也具有遗传毒性。因此,DL-ZAMI 1305芳香环或侧链化学结构的改变会影响该分子在雄性和雌性大鼠肝脏中的遗传毒性活性。本研究中所探究的DL-ZAMI 1305侧链修饰可能是该分子肝脏代谢的结果而在体内发生。肝脏药物代谢系统活性的性别依赖性差异可能解释了DL-ZAMI 1305在两性中不同的遗传毒性和致癌活性。

相似文献

1
Chemical structure and genotoxic activity of the hepatocarcinogenic beta-blocker DL-ZAMI 1305.肝癌致癌性β受体阻滞剂DL-ZAMI 1305的化学结构与遗传毒性活性
Carcinogenesis. 1990 Feb;11(2):261-5. doi: 10.1093/carcin/11.2.261.
2
Liver genotoxic activity of an epoxide derivative of the hepatocarcinogenic beta-blocker DL-ZAMI 1305.肝癌致癌性β受体阻滞剂DL-ZAMI 1305的一种环氧化物衍生物的肝脏遗传毒性活性。
Cancer Lett. 1990 Nov 19;55(1):61-6. doi: 10.1016/0304-3835(90)90066-7.
3
Critical role of gonadal hormones on the genotoxic activity of the hepatocarcinogen DL-ZAMI 1305.性腺激素对肝癌致癌物DL-ZAMI 1305遗传毒性活性的关键作用。
Cancer Lett. 1987 Sep;36(3):253-61. doi: 10.1016/0304-3835(87)90018-8.
4
Further studies on the tumor-initiating activity of the beta-blocker DL-ZAMI 1305.关于β受体阻滞剂DL-ZAMI 1305肿瘤起始活性的进一步研究。
Toxicol Pathol. 1986;14(4):470-6. doi: 10.1177/019262338601400415.
5
In vitro and in vivo DNA damage of male and female rat liver nuclei by oncogenic and nononcogenic beta blockers.
J Natl Cancer Inst. 1983 Apr;70(4):747-52.
6
Tumor-initiating activity of the beta-blocker ZAMI 1305 in the liver of the female Wistar rat.β受体阻滞剂ZAMI 1305在雌性Wistar大鼠肝脏中的肿瘤起始活性。
Cancer Lett. 1984 Nov;25(1):1-11. doi: 10.1016/s0304-3835(84)80019-1.
7
Liver tumors induced by a new beta-adrenoreceptor blocking agent in female rats.一种新型β-肾上腺素能受体阻滞剂在雌性大鼠中诱导产生的肝脏肿瘤。
J Natl Cancer Inst. 1982 Apr;68(4):669-72.
8
Inhibition of DNA and RNA synthesis in rat liver nuclei by oncogenic and non-oncogenic beta-blockers.致癌和非致癌β受体阻滞剂对大鼠肝细胞核中DNA和RNA合成的抑制作用。
Toxicol Pathol. 1985;13(1):18-25. doi: 10.1177/019262338501300104.
9
Optical isomers of the hepatocarcinogenic beta-blocker ZAMI 1305: influence on nucleic acids synthesis and DNA integrity.具有肝癌致癌性的β受体阻滞剂ZAMI 1305的光学异构体:对核酸合成及DNA完整性的影响
Chem Biol Interact. 1984 Jun;50(1):77-86. doi: 10.1016/0009-2797(84)90133-9.
10
Age-dependent, seasonal and daily variations of the DNA damaging capacity of the hepatocarcinogen ZAMI 1305 in female rat liver.
Cancer Lett. 1984 Jul;23(3):245-51. doi: 10.1016/0304-3835(84)90090-9.